Abstract
purpose. To test whether the high variability observed when measuring pattern
electroretinogram (PERG), visual evoked potentials (VEP), and spatial
contrast sensitivity (SCS) in eyes with ocular hypertension is
associated with variation in nerve fiber layer thickness, as measured
by optical coherence tomography (OCT).
methods. The study involved 32 untreated eyes (32 patients; age range, 29–64
years) showing a normal white-on-white 24/2 Humphrey (San Leandro, CA)
perimetry, IOP between 23 and 28 mm Hg, best corrected acuity of 20/20
or better, and none of the following papillary signs on conventional
color stereo slides: rim notch(es), peripapillary splinter hemorrhages,
or increased vertical-to-horizontal cup-to-disc ratio. On recruitment,
each eye underwent SCS testing, OCT, PERG, and VEP recordings. Linear
regression (Pearson’s test) or Spearman’s rank regression was adopted
for the analysis of the data.
results. The 95% confidence limits of the electrophysiological data were: PERG
P50 latency, 59.3 to 63 msec; PERG P50 to N95 amplitude, 0.74 to 1.15μ
mV; VEP P100 latency, 113 to 118 msec; VEP N75 to P100 amplitude,
3.81 to 4.90 μmV. The 360° nerve fiber layer thickness overall
(NFLO) ranged between 113 and 169 μm (145 ± 16 μm; mean ± SD) and significantly correlated with PERG P50 to N95 amplitude
(r: 0.518; P = 0.002), PERG P50
latency (r: −0.470; P = 0.007), VEP
N75 to P100 amplitude (r: 0.460; P =
0.008), VEP P100 latency (r = −0.422; P = 0.016) and SCS at 3 cyc/deg (r:−
0.358; P = 0.044).
conclusions. The variability of PERG, VEP, and SCS testing observed in eyes with
ocular hypertension is associated with differences in NFL thickness
(the thinner the layer, the worse the visual
function).
Psychophysical
1 and
electrophysiological
2 3 experiments have described
impaired visual function in human eyes having high intraocular pressure
(IOP) but showing a normal visual field tested by white-on-white
computer-assisted static perimetry. However, a significant overlap
exists between normal subjects and those with ocular
hypertension.
2 3
Optical coherence tomography (OCT), a recently developed technique,
allows in vivo scanning of the retinal layers. The device is based on
the interferometry principle, with a superluminescent diode used as a
source. The resolution limits are approximately 10 μm.
4 Measurements of retinal thickness are obtained automatically by means
of a computer algorithm that searches for the characteristic changes in
reflectivity observed at the superficial and deep retinal
boundaries.
4 Experiments performed on glaucomatous eyes
have extensively shown topographical correlation between visual field
defects and localized or diffused thinning of the nerve fiber layers
(NFLs).
5
We applied OCT to eyes with ocular hypertension and no visual field
defects. The data on the NFLs were then correlated with both
electrophysiological (pattern electroretinogram [PERG] and visual
evoked potentials [VEPs]) and psychophysical (spatial contrast
sensitivity [SCS]) parameters. Thus, we tested whether the reported
variability is associated with interindividual variation in NFL
thickness.
Thirty-two eyes of 32 consecutive patients (age range, 29–64
years, mean, 48 ± 9 years) affected by ocular
hypertension were recruited. Each patient had to be experienced with
automatic perimetry (at least six reliable examinations within the
previous 3 years). Enrollment was conducted according to the following
inclusion criteria: IOP more than 23 mm Hg and less than 28 mm Hg
(average of the two highest readings of the daily curve, from 8:00 AM
to 6:00 PM, six independent readings, one every 2 hours); normal
automatic full threshold perimetry (24/2 Humphrey, mean defect,
corrected pattern standard deviation and glaucoma hemifield test within
the normal range of the database of the Humphrey [San Leandro, CA])
software; fixation losses, false-positive rate and false-negative rate
each <20%); best corrected visual acuity 20/20 or better; none of the
following papillary signs on conventional color stereo slides: rim
notch(es), peripapillary splinter hemorrhages, increased
vertical-to-horizontal cup-to-disc ratio, cup-to-disc asymmetry between
the two eyes less than 0.2; mean refractive error (when present)
between −0.50 and +0.50 spherical equivalent; no previous history of
diabetes, optic neuritis, or any disease involving the anterior visual
pathways; and pupil diameter 3 mm or more.
On recruitment, each patient provided informed consent to the
procedures. The research followed the tenents of the Declaration of
Helsinki.
Each eye underwent the following procedures: SCS testing and OCT were
performed on the same day; PERG and VEP recordings were performed 1
week later.
OCT (Humphrey) was performed using a fiber-optic delivery system
coupled with slit lamp biomicroscope. This system provides the operator
with a video camera view of the scanning probe beam on the fundus and
an OCT image acquired in real time on a computer monitor.
After dilation with 1% tropicamide, each eye was scanned three times
using a 3.4-mm circle (1.7-mm radius). Near-infrared light (840-nm
wavelength) was used. Throughout scanning, the patient kept the eyes
fixed on an internal target provided by the equipment. The measurements
were obtained from three nonconsecutive scans (i.e., the patient was
allowed to rest for a few seconds before repositioning to proceed to
the next scan).
The OCT software has an automated computer algorithm that identifies
the anterior and posterior border of the retina, making it possible to
calculate NFL and total retinal thickness overall by quadrant and by
clock hour.
In the assessed eyes, we considered the average of the values obtained
by three different measurements in each quadrant: superior (NFLS),
inferior (NFLI), nasal (NFLN), and temporal (NFLT); the overall data
obtained in all quadrants (12 values averaged) were identified as NFL
overall (NFLO).
Foveal SCS was tested by using a commercial available chart
(CSV1000 (Vector Vision, Daytona, OH). The CSV1000 provides a
fluorescent luminance source that retroilluminates a translucent chart.
The instrument houses a series of photocells that automatically monitor
and calibrate the instrument light level to 85 candelas
(cd)/m2 ± 0.1 log unit. At the testing distance of
8 feet, the translucent chart presents four spatial frequencies, each
on a separate row of the test: 3, 6, 12, and 18 cyc/deg. Sensitivity
levels at each frequency range from 0.7 to 2.08 (3 cyc/deg), 0.91 to
2.29 (6 cyc/deg), 0.61 to 1.99 (12 cyc/deg), and 0.17 to 1.55 (18
cyc/deg) log units.
The procedure described by Pomerance and Evans
1 was
followed. Sensitivity threshold was measured two times, allowing only a
few seconds between measurements. Only the second measurements were
considered for analysis. The test–retest variability was consistent
with that reported previously
1 .
This bioelectrical signal was recorded by a small Ag/AgCl skin
electrode placed over the lower eyelid. PERGs were derived bipolarly
between the stimulated eye (active electrode) and the patched eye
(reference electrode). The ground electrode was in Fpz. The
interelectrode resistance was lower than 3 kΩ.
The signal was amplified (gain 50,000), filtered (band-pass, 1–30Hz),
and averaged with automatic rejection of artifacts (200 events free
from artifacts were averaged for every trial) by BM 6000
(Biomedica Mangoni, Pisa, Italy). The analysis time was 250 msec.
The transient PERG response is characterized by a series of waves with
three subsequent peaks, of negative, then positive, then negative
polarity. In normal subjects when the conditions of our experiment are
used, these peaks have the following mean latencies: 35, 50, and 95
msec.
Cup-shaped Ag/AgCl electrodes were fixed with collodion in the
following positions: active electrode at Oz, reference electrode at
Fpz, ground on the left arm. The interelectrode resistance was kept
below 3 kΩ. The bioelectric signal was amplified (gain 20,000),
filtered (band-pass, 1–100 Hz), and averaged (200 events free from
artifacts were averaged for every trial) by BM 6000. The analysis time
was 250 msec.
The transient VEP response is characterized by a series of waves with
three sequential peaks, of negative, then positive, then negative
polarity. In normal subjects and in the conditions of our experiment,
these peaks have the following mean latencies: 75, 100, and 145 msec.
In the recording session, simultaneous PERGs and VEPs were recorded
with at least two replications, and the resultant waveforms were
superimposed to check the repeatability of the results. We accepted
PERG and VEP signals with signals-to-noise ratio more than 2. The noise
was measured by recording the bioelectrical signals (200 averaged
events) while the monitor was screened by a cardboard and a noise less
than 0.1 μV (mean 0.085 μV) was observed in all subjects tested.
For all PERGs and VEPs the peak latency and the peak amplitude of each
of the averaged waves were measured directly on the displayed records
by means of a pair of cursors. By comparing the VEP peak latency (P100)
and the PERG peak latency (P50), it is possible to have an index of
postretinal neural conduction. We call the difference between VEP P100
latency and PERG P50 latency retinocortical time (RCT).
3
In this study, we examined eyes with ocular hypertension and no
evidence of field damage, and we measured NFL thickness (OCT), PERGs,
VEPs, and SCS.
When considering eyes affected by high IOP and no sign of field damage,
the actual risk for a conversion to glaucoma is not presently known.
Because our study was carried out cross-sectionally, no information is
available to determine which eye would eventually have a field defect.
The NFL thickness range obtained by OCT analysis in our study eyes is
consistent with that previously reported in a similar
population.
6 Most of the eyes showed OCT values well above
the suggested lower limits for normal subjects (125–135μ
m).
5 The scattering of the electrophysiological data
(see.
Fig. 1 ) is consistent with that previously observed by
investigators in several studies of ocular
hypertension.
2 3 When plotting the data as a function of
the OCT values, data can be fit by linear regression. A similar
phenomenon is observed for the 3-cyc/deg threshold of SCS. These
correlations, albeit moderate (see
Table 2 ), show a strong
significance. This result suggests that eyes having a thinner ganglion
cell layer, produce smaller electrophysiological (both retinal [PERG]
) and cortical [VEP ]) and psychophysical responses.
Several psychophysical studies have found that contrast sensitivity to
low spatial frequency patterns is impaired in patients affected by
glaucoma
7 and that the difference between glaucoma and
other diseases, leading to a pathologic contrast sensitivity, appears
to be in the low-frequency region
8. As pointed out by
Bodis–Wollner,
8 low spatial frequency refers to patterns
with a frequency near, but lower than, the peak of the human foveal
contrast sensitivity curve. Three cycles per degree fits this model.
Should a lower signal from the OCT (i.e., a thinner NFL) represent a
sign of early ganglion cell loss,
7 3 cyc/deg would be the
most likely affected frequency among those tested by the CSV1000 chart.
Not surprisingly, then, 3 cyc/deg was the only frequency with a
threshold that correlated well with the NFL thickness in our series of
hypertensive eyes (see
Table 2B ).
Studies performed in animal models have shown that the PERG reflects
the bioelectrical activity of the innermost retinal layers (the
ganglion cells and their fibers).
9 The existence of
similar evidence in humans is still controversial.
10 However, if the PERG generators in humans are in the innermost retinal
layers, then our data show an intriguing relationship between an
electrophysiological bioelectrical response (PERG) and its supposed
anatomic counterpart (i.e., the innermost retina) in humans.
Age may have been a potentially confounding factor in the analysis of
the data. However, as shown in
Table 2A , there was no correlation
between age and NFL thickness measured in our cohort of patients.
Therefore, we believe that this potential source of bias was, in our
study, negligible.
We also observed a strong correlation between VEP
electrophysiology and OCT. The cortical evoked response (VEP) is
derived from retinal activity together with neural conduction along the
visual pathways.
3 When simultaneously recording PERG and
VEP, an index of neural conduction (the so-called RCT) can be
obtained.
3 In patients with glaucoma, a delay in
postretinal visual pathways (i.e., increased RCT) has only been
observed once an eye has an actual field defect.
3 Eyes
with ocular hypertension, but without field defects, have shown normal
postretinal neural conduction.
3 Comparable data may be
obtained from the recordings obtained in our cohort of patients. As
shown in
Table 1 , RCT calculated in our study (54.8 ± 4.55 msec)
can be superimposed on that previously reported in a cohort of patients
with ocular hypertension (54.3 ± 4.12 msec)
3 . We
can, therefore, assume that the postretinal neural conduction in our
cohort of patients was within the normal range. Therefore, the
variability of the VEP response, observed in our patients, would be
best explained by differences in the retinal anatomy only. The
correlation between NFL thickness and the VEP responses (see
Table 2A )
suggests that, in our cohort of ocular hypertensive eyes, the neural
conduction in the visual pathways was dominated by the retinal
component (i.e., the thinner the layers, the worse the conduction).
In conclusion, the data collected in our study show that the
variability of the PERG, VEP and SCS threshold observed in eyes with
ocular hypertension, is correlated with interindividual variation in
NFL thickness (the thinner the layer, the worse the visual function).
In human eyes, the NFL thickness measured by OCT is correlated with
electrophysiological responses assumed to be originating in the
innermost retinal layers.
However, we want to emphasize that a significant correlation between
two factors does not imply causality. Other as yet unrecognized factors
may contribute to the observed variability of functional parameters in
eyes with ocular hypertension.
Reprint requests: Vincenzo Parisi, Via S. Maria Goretti 66, 00199 Roma, Italy.
Submitted for publication July 20, 1998; revised February 23, 1999; accepted April 1, 1999.
Proprietary interest category: N.
Table 1. Table 1.
Observed Characteristics in Patients with Ocular Hypertension
Table 1. Table 1.
Observed Characteristics in Patients with Ocular Hypertension
| Age (y) | IOP* | NFLO, † | NFLS | NFLI | NFLN | NFLT | P50, ‡ | P50–N95, § | P100, ∥ | N75–P100, ¶ | RCT, # | SCS 3 cyc/deg | SCS 6 cyc/deg | SCS 12 cyc/deg | SCS 18 cyc/deg |
RG | 58 | 26 | 113 | 120 | 142 | 123 | 66 | 70 | 0.5 | 124 | 2.0 | 54 | 1.64 | 1.85 | 1.40 | 0.96 |
PS | 56 | 25 | 123 | 127 | 149 | 112 | 104 | 63 | 0.7 | 112 | 4.0 | 49 | 1.49 | 1.38 | 1.25 | 0.64 |
PC | 58 | 24 | 125 | 136 | 142 | 111 | 107 | 63 | 0.5 | 117 | 5.7 | 54 | 1.49 | 1.55 | 1.40 | 1.11 |
CA | 48 | 26 | 129 | 157 | 135 | 123 | 102 | 68 | 0.7 | 121 | 4.8 | 53 | 1.49 | 1.85 | 1.55 | 1.11 |
PA | 56 | 25 | 135 | 139 | 154 | 157 | 91 | 62 | 0.4 | 116 | 6.9 | 54 | 1.49 | 1.55 | 1.40 | 1.11 |
CR | 61 | 23 | 136 | 133 | 145 | 130 | 136 | 64 | 0.7 | 120 | 2.6 | 56 | 1.17 | 1.38 | 1.08 | 0.64 |
PD | 49 | 24 | 143 | 166 | 162 | 135 | 111 | 66 | 1.0 | 120 | 5.3 | 54 | 1.49 | 1.85 | 1.40 | 1.26 |
CB | 48 | 26 | 143 | 139 | 151 | 148 | 124 | 67 | 0.7 | 124 | 2.9 | 57 | 1.49 | 1.85 | 1.55 | 1.11 |
CL | 47 | 24 | 147 | 158 | 178 | 135 | 117 | 68 | 1.2 | 125 | 2.3 | 57 | 1.49 | 1.85 | 1.40 | 0.96 |
PB | 49 | 26 | 151 | 167 | 162 | 160 | 115 | 60 | 0.8 | 120 | 3.8 | 60 | 1.49 | 1.85 | 1.40 | 1.26 |
LT | 52 | 22 | 160 | 170 | 176 | 152 | 142 | 61 | 0.8 | 125 | 2.6 | 64 | 1.49 | 1.38 | 1.08 | 0.64 |
CI | 64 | 24 | 152 | 170 | 170 | 148 | 121 | 66 | 1.1 | 115 | 5.4 | 49 | 1.49 | 1.70 | 1.25 | 0.96 |
SB | 58 | 25 | 163 | 168 | 170 | 165 | 161 | 59 | 1.1 | 116 | 5.2 | 57 | 1.17 | 1.38 | 0.91 | 0.81 |
PR | 56 | 26 | 167 | 174 | 176 | 161 | 157 | 62 | 1.0 | 113 | 5.6 | 51 | 1.34 | 1.85 | 1.55 | 0.64 |
CB | 38 | 24 | 165 | 176 | 179 | 140 | 166 | 60 | 1.3 | 112 | 5.5 | 52 | 1.34 | 1.70 | 1.85 | 1.11 |
TR | 52 | 24 | 128 | 136 | 146 | 114 | 116 | 68 | 0.6 | 125 | 2.4 | 57 | 1.49 | 1.70 | 1.25 | 0.81 |
VS | 35 | 25 | 160 | 143 | 189 | 161 | 149 | 57 | 0.8 | 118 | 4.8 | 61 | 1.34 | 1.85 | 1.55 | 1.11 |
FD | 35 | 23 | 127 | 141 | 142 | 106 | 122 | 68 | 0.5 | 119 | 2.2 | 51 | 1.34 | 1.85 | 0.91 | 0.81 |
SC | 58 | 23 | 169 | 178 | 184 | 163 | 142 | 61 | 1.2 | 116 | 6.2 | 55 | 1.17 | 1.38 | 1.08 | 0.81 |
BT | 45 | 23 | 159 | 186 | 159 | 137 | 155 | 52 | 1.8 | 102 | 6.2 | 50 | 1.64 | 1.85 | 1.55 | 1.11 |
LB | 45 | 25 | 127 | 143 | 140 | 118 | 108 | 52 | 1.6 | 117 | 3.6 | 65 | 1.64 | 1.70 | 1.40 | 0.96 |
PD | 48 | 26 | 151 | 163 | 165 | 146 | 148 | 58 | 1.2 | 103 | 7.2 | 45 | 1.49 | 1.55 | 1.25 | 0.64 |
GI | 49 | 24 | 140 | 147 | 158 | 136 | 119 | 54 | 1.2 | 115 | 3.8 | 61 | 1.49 | 1.85 | 1.55 | 1.11 |
TI | 49 | 25 | 158 | 154 | 167 | 155 | 157 | 63 | 1.0 | 114 | 3.9 | 51 | 1.34 | 1.70 | 1.40 | 0.64 |
RE | 29 | 26 | 131 | 129 | 133 | 133 | 129 | 59 | 1.1 | 113 | 4.0 | 54 | 1.79 | 2.00 | 1.70 | 1.41 |
EF | 30 | 24 | 156 | 178 | 175 | 157 | 115 | 55 | 0.9 | 111 | 4.1 | 56 | 1.49 | 2.00 | 1.70 | 1.41 |
OL | 42 | 24 | 136 | 157 | 167 | 128 | 89 | 58 | 1.2 | 110 | 5.2 | 52 | 1.49 | 1.85 | 1.70 | 0.96 |
VO | 44 | 26 | 154 | 187 | 173 | 127 | 129 | 56 | 1.2 | 113 | 4.0 | 57 | 1.34 | 1.70 | 1.55 | 0.64 |
SP | 48 | 22 | 165 | 188 | 193 | 122 | 157 | 55 | 1.4 | 103 | 7.2 | 48 | 1.49 | 1.85 | 1.40 | 0.81 |
BE | 39 | 23 | 120 | 132 | 142 | 110 | 93 | 66 | 0.5 | 125 | 2.3 | 59 | 1.64 | 1.85 | 1.55 | 1.26 |
ED | 41 | 26 | 167 | 196 | 187 | 148 | 135 | 57 | 1.0 | 114 | 4.0 | 57 | 1.49 | 1.85 | 1.55 | 1.11 |
CS | 60 | 25 | 147 | 149 | 153 | 133 | 133 | 60 | 0.7 | 114 | 3.9 | 54 | 1.17 | 1.55 | 1.25 | 0.64 |
Table 2. Table 2.
Linear Regression (A) and Rank Regression (B)
between NFL Thickness and Electrophysiological or SCS Parameters
Table 2. Table 2.
Linear Regression (A) and Rank Regression (B)
between NFL Thickness and Electrophysiological or SCS Parameters
(A) | Age | IOP | PERG P50 Latency | PERG P50–N95 Amplitude | VEP P100 Latency | VEP N75–P100 Amplitude | RCT (P100–P50) |
NFLO | r: −0.034 | r: −0.096 | r: −0.470 | r: 0.518 | r: −0.422 | r: 0.460 | r: −0.071 |
| t: −0.187 | t: −0.527 | t: −2.916 | t: 3.318 | t: −2.546 | t: 2.835 | t: −0.389 |
| P = 0.853 | P = 0.602 | P = 0.007 | P = 0.002 | P = 0.016 | P = 0.008 | P = 0.700 |
NFLS | r: −0.102 | r: −0.130 | r: −0.476 | r: 0.606 | r: −0.485 | r: 0.474 | r: −0.140 |
| t: −1.565 | t: −0.716 | t: −2.968 | t: 4.168 | t: −3.035 | t: 2.949 | t: −0.775 |
| P = 0.575 | P = 0.480 | P = 0.006 | P <0.000 | P = 0.005 | P = 0.006 | P = 0.443 |
NFLI | r: 0.065 | r: −0.190 | r: −0.378 | r: 0.422 | r: −0.334 | r: 0.391 | r: −0.041 |
| t: 0.361 | t: −1.059 | t: −2.238 | t: 2.549 | t: −1.951 | t: 2.328 | t: −0.225 |
| P = 0.720 | P = 0.298 | P = 0.033 | P = 0.015 | P = 0.060 | P = 0.026 | P = 0.816 |
NFLN | r: 0.086 | r: 0.216 | r: −0.253 | r: 0.181 | r: −0.126 | r: 0.344 | r: 0.107 |
| t: 0.475 | t: 1.216 | t: −1.435 | t: 1.009 | t: −0.695 | t: 2.005 | t: 0.587 |
| P = 0.637 | P = 0.233 | P = 0.162 | P = 0.321 | P = 0.493 | P = 0.054 | P = 0.561 |
NFLT | r: −0.061 | r: −0.151 | r: −0.404 | r: 0.493 | r: −0.447 | r: 0.349 | r: −0.168 |
| t: −0.335 | t: −0.839 | t: −2.420 | t: 3.102 | t: −2.738 | t: 2.109 | t: −0.935 |
| P = 0.740 | P = 0.408 | P = 0.022 | P = 0.004 | P = 0.010 | P = 0.043 | P = 0.357 |
(B) | SCS 3 cyc/deg | SCS 6 cyc/deg | SCS 12 cyc/deg | SCS 18 cyc/deg |
NFLO | r: −0.359 | r: 0.004 | r: 0.098 | r: −0.138 |
| P = 0.044 | P = 0.980 | P = 0.590 | P = 0.448 |
NFLS | r: −0.225 | r: 0.081 | r: 0.132 | r: −0.054 |
| P = 0.216 | P = 0.661 | P = 0.471 | P = 0.767 |
NFLI | r: −0.371 | r: 0.050 | r: 0.085 | r: −0.160 |
| P = 0.037 | P = 0.784 | P = 0.645 | P = 0.383 |
NFLN | r: −0.343 | r: 0.096 | r: 0.012 | r: −0.042 |
| P = 0.054 | P = 0.602 | P = 0.946 | P = 0.822 |
NFLT | r: −0.412 | r: −0.093 | r: −0.073 | r: −0.340 |
| P = 0.020 | P = 0.611 | P = 0.688 | P = 0.057 |
Pomerance GN, Evans DW. Test-retest reliability of the CSV1000 contrast test and its relationship to glaucoma therapy. Invest Ophthalmol Vis Sci
. 1994;35:3357–3361.
[PubMed]Pfeiffer N, Tillmon B, Bach M. Predictive value of the pattern electroretinogram in high-risk ocular hypertension. Invest Ophthalmol Vis Sci
. 1993;34:1710–1715.
[PubMed]Parisi V. Neural conduction in the visual pathways in ocular hypertension and glaucoma. Graefes Arch Ophthalmol
. 1997;235:136–142.
[CrossRef] Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science
. 1991;254:1178–1181.
[CrossRef] [PubMed]Swanson A, Fujimoto JG. Quantification of nerve layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol
. 1995;113:586–596.
[CrossRef] [PubMed]Williams JM, Zangwill L, Weinreb RN. Measurement of the nerve fiber
layer using the optical coherence tomography (Heidelberg retina
tomograph) and the nerve fiber analyzer II. [ARVO Abstracts].
Invest Ophthalmol Vis Sci. 1997;38(4):S837.
Arden G, Jacobson J. A simple grating test for contrast sensitivity: preliminary results indicate value for screening in glaucoma. Invest Ophthalmol Vis Sci
. 1978;17:23–32.
[PubMed]Bodis–Wollner I. Electrophysiolgical and psychophysical
testing of vision in glaucoma. Surv Ophthalmol.
1989;33(suppl):301–307.
Maffei L, Fiorentini A. Electroretinographic responses to alternating gratings before and after section of the optic nerve. Science
. 1981;211:953–955.
[CrossRef] [PubMed]Odom JV, Maida TM, Dawson WW. Pattern evoked retinal responses (PERR) in human: effects of spatial frequency, luminance and the focus. Curr Eye Res. 1983;2:99–108.